Miltenyi Biotec is a private German company founded in 1989 by Stefan Miltenyi. For almost 30 years, Miltenyi Biotec has played an important role in the design, development, manufacturing, and integration of products that empower the advancement of biomedical research and enable cell and gene therapy. We are more than 3 000 scientists, engineers, physicians, support specialists, marketers – all dedicated to improve scientific understanding and impacting human lives. In the past decades, we have built  innovative technologies for Sample Preparation, Cell Separation, Cell Culture, Flow Cytometry, Imaging & Cell & Gene therapy One of our principal tasks is to design and coordinate clinical studies to test the therapeutic utility of Miltenyi Biotec’s clinical products in areas such as regenerative medicine and stem cell therapy, with an emphasis on hemato-oncological, infectious, and cancer immunotherapy. Working with many internationally recognized professionals in centers throughout the world, we carry out a number of trials that range from safety/feasibility (phase I/II) to pivotal stage (phase III) and post-market surveillance trials. Additionally, our products are used in independent academic trials in the above mentioned therapeutic areas.